Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The SEPT9 gene methylation assay is capable of detecting colorectal adenoma in opportunistic screening

1 May 2017

Abstract excerpt

AIM: This study validated the detection of colorectal adenoma in opportunistic screening using the SEPT9 gene methylation assay. MATERIALS & METHODS: Plasma samples including 85 colorectal cancers, 364 adenomas, 216 hyperplastic polyps, 372 other gastrointestinal diseases and 324 normal subjects, were obtained and tested using the Epi proColon 2.0 CE assay. RESULTS & CONCLUSION: The SEPT9 assay detected 38.7% of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Cancer Screening and Detection
Share to Gastric Cancer Management and Outcomes
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28470092
DOI: 10.2217/epi-2016-0146

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The SEPT9 gene methylation assay is capable of detecting colorectal adenoma in opportunistic screeningPMID 28470092Read ↗

Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detectionSemantic proximity Read ↗

Colorectal Cancer Screening Methods and Molecular Markers for Early Detection.Semantic proximity Read ↗

Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation AssaySemantic proximity Read ↗

Aberrant DNA Methylation of SEPT9 and SDC2 in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early DetectionSemantic proximity Read ↗

Diagnostic value of new combination of methylated Septin9 with LMR in adenomatous polyps and stage I to IV colorectal cancerSemantic proximity Read ↗

Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal CancerSemantic proximity Read ↗

The Screening Value of Septin9, SDC2, and BCAT1 Triple Gene Methylation Detection Combined with Colonoscopy for Early Colorectal CancerSemantic proximity Read ↗

Roles of Methylated DNA Biomarkers in Patients with Colorectal CancerSemantic proximity Read ↗

Plasma methylated septin 9: a colorectal cancer screening markerSemantic proximity Read ↗

From Discovery to the Clinic: The Novel DNA Methylation Biomarker <i> <sup>m</sup> </i> SEPT9 For The Detection of Colorectal Cancer in BloodSemantic proximity Read ↗

SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomasSemantic proximity Read ↗

Detection of colorectal cancer in urine using DNA methylation analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.